Securities Class Action Against GPGI (Formerly CompoSecure) Adds Legal Overhang to Already Stretched Valuation

What happened

Rosen Law Firm announced a securities class action against GPGI, Inc. (formerly CompoSecure, CMPO), with a September 14, 2026 lead plaintiff deadline for purchasers between November 3, 2025 and May 6, 2026 who lost over $100,000. The class period covers the period leading up to and following the company's $5 billion Husky Technologies acquisition, which closed in January 2026 and was accompanied by significant equity dilution and debt issuance. The DeepValue master report had already flagged CompoSecure as a 'POTENTIAL SELL' due to its stretched valuation, heavy leverage, complex holding company structure, and crowded long positioning, with a base case fair value of $24 versus the current $25.15. The new litigation adds a legal overhang that could distract management, consume cash, and further pressure the stock if the allegations are substantiated. While the specific claims are not yet detailed, the class action reinforces the bear case scenario that integration and execution risks may be more severe than the market currently prices.

Implication

Investors should treat the class action as a new negative catalyst that increases the probability of the bear case, where litigation costs and management distraction could derail the Husky integration and deleveraging timeline. The class period overlaps with the period when CompoSecure promoted the Husky acquisition and guided to aggressive pro forma EBITDA and EPS accretion, raising the possibility that the market was misled about Husky's growth or synergies. With the stock trading at $25.15, above the base-case implied value of $24, and with a crowded long position, the risk-reward remains skewed to the downside even before accounting for potential litigation liabilities. The company already carries $2 billion of new debt and a $253.7 million Tax Receivable Agreement, so any settlement or adverse judgment would further strain cash flows and complicate deleveraging efforts. Given these factors, investors should consider trimming positions, and those with a lower risk tolerance should wait for either a meaningful pullback below $20 or clear evidence that the litigation is immaterial before adding exposure.

Thesis delta

The class action does not change the fundamental assessment that CompoSecure is overvalued relative to its base-case intrinsic value. However, it does increase the risk of a negative outcome by adding potential legal costs, management distraction, and reputational damage. This shifts the probability distribution slightly toward the bear case, but the overall thesis remains 'POTENTIAL SELL' with no reason to upgrade.